Abstract
This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Abnormalities, Drug-Induced*
-
Administration, Oral
-
Adult
-
Antiemetics / administration & dosage
-
Antiemetics / adverse effects*
-
Cleft Lip / chemically induced
-
Cleft Palate / chemically induced
-
Female
-
Follow-Up Studies
-
Heart Defects, Congenital / chemically induced
-
Humans
-
Injections, Intravenous
-
Nausea / drug therapy
-
Ondansetron / administration & dosage
-
Ondansetron / adverse effects*
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Pregnancy Trimester, First
-
Risk